Chargement en cours...
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
The neuraminidase inhibitors zanamivir and oseltamivir are marketed for the treatment and prophylaxis of influenza and have been stockpiled by many countries for use in a pandemic. Although recent surveillance has identified a striking increase in the frequency of oseltamivir-resistant seasonal infl...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology (ASM)
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2753113/ https://ncbi.nlm.nih.gov/pubmed/19641000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01200-09 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|